Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Building the Hybrid Cloud
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal Tech Talk
- The Future of Government Data Centers
- The Future of IT: How CIOs Can Enable the Service-Oriented Enterprise
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- The New Generation of Database
- Satellite Communications: Acquiring SATCOM in Tight Times
- Targeting Advanced Threats: Proven Methods from Detection through Remediation
- Transformative Technology: Desktop Virtualization in Government
- The Truth About IT Opex and Software Defined Networking
- Value of Health IT
- Air Traffic Management Transformation Report
- Cloud First Report
- General Dynamics IT Enterprise Center
- Gov Cloud Minute
- Government in Technology Series
- Homeland Security Cybersecurity Market Report
- National Cybersecurity Awareness Month
- Technology Insights
- The Cyber Security Report
- The Next Generation Cyber Security Experts
Shows & Panels
St. Jude gets EU approval for wireless pacemaker
Monday - 10/14/2013, 9:08am EDT
ST. PAUL, Minn. (AP) -- A first-of-its-kind wireless pacemaker will soon be on its way to market in Europe, but not the U.S.
St. Jude Medical says it will announce Monday that it received European approval to market the device.
The device was developed by California-based startup, Nanostim, with funding from St. Jude. The Minnesota-based device giant also said it would acquire the smaller company for $123 million.
Pacemakers help the heart maintain a steady heartbeat. The traditional surgical procedure creates a small pocket in the chest for the device and its wires, which attach to the heart.
The new Nanostim pacemaker is implanted directly into the heart using a less intensive, catheter-based procedure.
St. Jude is still conducting required studies of the device in the U.S.
St. Jude has been plagued in recent years by recalls of lead wires with its other leading product, defibrillators, which correct dangerous irregular heartbeats.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.